Oculis Holding AG (OCS) Non-Current Assets (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Non-Current Assets of $21.7 million in Q1 2026, up 1.36% quarter-over-quarter from $21.4 million in Q4 2025, and up 26.56% on a YoY basis from $17.1 million in Q1 2025.

Oculis Holding AG (OCS) Non-Current Assets (2021 - 2026) Analysis & Trends

Oculis Holding AG's Non-Current Assets history runs 6 years deep, the most recent figure standing at $21.7 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 26.56% year-over-year to $21.7 million; the TTM figure through Mar 2026 stood at $21.7 million (up 26.56% YoY), while the FY2025 annual figure was $21.4 million, up 21.08% from the prior year.
  • Non-Current Assets was $21.7 million for Q1 2026 at Oculis Holding AG, up from $21.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $21.7 million in Q1 2026 to a low of $13.9 million in Q4 2022.
  • Historically, Non-Current Assets has averaged $17.2 million across 5 years, with a median of $16.3 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets increased 4.02% in 2024, then grew 29.88% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $13.9 million in 2022, then grew by 8.08% to $15.0 million in 2023, then grew by 17.34% to $17.6 million in 2024, then advanced by 21.08% to $21.4 million in 2025, then climbed by 1.36% to $21.7 million in 2026.
  • The last three Non-Current Assets figures came in at $21.7 million (Q1 2026), $21.4 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 62,953.78
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 4.56 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 30.30 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 14.75 Bn
9 Abivax 90.15 Bn 90.15 Bn - 39.71 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 21.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.65 Mn
Dec 31, 2025 21.36 Mn
Sep 30, 2025 21.16 Mn
Jun 30, 2025 18.63 Mn
Mar 31, 2025 17.11 Mn
Dec 31, 2024 17.64 Mn
Sep 30, 2024 16.29 Mn
Jun 30, 2024 15.59 Mn
Mar 31, 2024 15.20 Mn
Dec 31, 2023 15.04 Mn
Sep 30, 2023 15.22 Mn
Jun 30, 2023 14.99 Mn
Dec 31, 2022 13.91 Mn
Dec 31, 2021 10.91 Mn